Treatment of Nodular Non-Pigmented Basal Cell Carcinoma on the Nose by the Chemical Procedure of Dr. G. Dunkic: A Case Report

Abstract

Background: Basal Cell Carcinoma (BCC) is the most common malignant skin tumor, frequently affecting sun-exposed areas such as the nose. Surgical excision remains the gold standard, but alternative approaches may be considered in elderly patients or those unwilling to undergo invasive procedures.
Case presentation: We describe an 82-year-old male with a nodular, non-pigmented lesion on the nose, measuring 25 × 15 × 10 mm, present for two years and showing accelerated growth after repeated trauma. Clinical examination confirmed nodular BCC with surface capillaries. The patient refused surgical excision and was treated using a proprietary chemical method developed by Dr. G. Dunkic, et al. A liquid preparation was applied topically without anesthesia or tissue penetration. Within 24–72 hours, a crust formed and detached after 15–20 days, resulting in complete epithelialization. Healing was uneventful, with no major complications.
Conclusion: This case demonstrates the potential of a chemical, non-invasive approach for nodular BCC removal. Further controlled studies are needed to validate efficacy and safety compared to conventional therapies.
Credit: Health Care Clinic Apiderm Plus, Health Care Clinic Dunkic
Restrictions: Not to be used for advertising or in a defamatory context.
The chemical method for removing lesions by Dr. G. Dunkic is proprietary, and unauthorized use is strictly prohibited. The proprietary chemical preparation used in this case is not disclosed in detail due to intellectual property protection. The focus of this report is on the clinical outcome rather than the composition of the agent.
Note on Method Availability: The mole removal method presented in this paper is the result of years of family-based experience and development. Due to its specificity, effectiveness, and practical value, the method is not publicly available for unrestricted use without prior agreement with the authors.
The authors are open to professional collaboration, including licensing, supervised clinical application, and research projects conducted under controlled conditions. Interested parties are invited to contact the authors directly using the information provided in this paper to discuss potential partnerships.
Our goal is to contribute to the advancement of alternative approaches in dermatological practice while preserving the integrity and ownership of the method.